Secretion of MMP-2 and MMP-9 induced by VEGF autocrine loop correlates with clinical features in childhood acute lymphoblastic leukemia

Leukemia Research

Volumn 33, Issue 3, 2009, Pages 407-417

  Poyer, Florent ^a   Coquerel, Bérénice ^a   Pegahi, Rassa ^a   Cazin, Lionel ^a   Norris, Vic ^a   Vannier, Jean Pierre ^a,b   Lamacz, Marek ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

ALL; Autocrine loop; MMP 2; MMP 9; Primary cells; VEGF

Indexed keywords

GELATINASE A; GELATINASE B; HEMOGLOBIN; VASCULOTROPIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; AUTOCRINE EFFECT; BLOOD SAMPLING; BONE MARROW BIOPSY; CANCER CELL CULTURE; CELL LINEAGE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOCHEMISTRY; DIAGNOSTIC PROCEDURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; INFANT; LEUKEMIA CELL; PARAMETER; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT FAILURE; TREATMENT RESPONSE;

ADOLESCENT; AUTOCRINE COMMUNICATION; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; HEMOGLOBINS; HUMANS; INFANT; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; REMISSION INDUCTION; TREATMENT FAILURE; TUMOR LYSIS SYNDROME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 58549119944     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.08.019     Document Type: Article

References (46)

1. Brown L.F., Detmar M., Claffey K., Nagy J.A., Feng D., Dvorak A.M., et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS 79 (1997) 233-269
2. Folkman J., and Klagsbrun M. Vascular physiology. A family of angiogenic peptides. Nature 329 (1987) 671-672
3. Takahashi Y., Kitadai Y., Bucana C.D., Cleary K.R., and Ellis L.M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55 (1995) 3964-3968
4. Volm M., Rittgen W., and Drings P. Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas. Br J Cancer 77 (1998) 663-669
5. Perez-Atayde A.R., Sallan S.E., Tedrow U., Connors S., Allred E., and Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 150 (1997) 815-821
6. Bellamy W.T., Richter L., Frutiger Y., and Grogan T.M. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 59 (1999) 728-733
7. Aguayo A., Estey E., Kantarjian H., Mansouri T., Gidel C., Keating M., et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 94 (1999) 3717-3721
8. Koomagi R., Zintl F., Sauerbrey A., and Volm M. Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction. Clin Cancer Res 7 (2001) 3381-3384
9. Ortega N., Hutchings H., and Plouet J. Signal relays in the VEGF system. Front Biosci 4 (1999) 141-152
10. Wen Y., Edelman J.L., Kang T., Zeng N., and Sachs G. Two functional forms of vascular endothelial growth factor receptor-2/Flk-1 mRNA are expressed in normal rat retina. J Biol Chem 273 (1998) 2090-2097
11. Longatto Filho A., Martins A., Costa S.M., and Schmitt F.C. VEGFR-3 expression in breast cancer tissue is not restricted to lymphatic vessels. Pathol Res Pract 201 (2005) 93-99
12. Pajusola K., Aprelikova O., Armstrong E., Morris S., and Alitalo K. Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts. Oncogene 8 (1993) 2931-2937
13. Cross M.J., Dixelius J., Matsumoto T., and Claesson-Welsh L. VEGF-receptor signal transduction. Trends Biochem Sci 28 (2003) 488-494
14. Ziegler B.L., Valtieri M., Porada G.A., De Maria R., Muller R., Masella B., et al. KDR receptor: a key marker defining hematopoietic stem cells. Science 285 (1999) 1553-1558
15. Munaut C., Noel A., Hougrand O., Foidart J.M., Boniver J., and Deprez M. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Int J Cancer 106 (2003) 848-855
16. Foda H.D., and Zucker S. Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug Discov Today 6 (2001) 478-482
17. Davidson B., Goldberg I., Gotlieb W.H., Kopolovic J., Ben-Baruch G., Nesland J.M., et al. The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma. Mol Cell Endocrinol 187 (2002) 39-45
18. Herrera C.A., Xu L., Bucana C.D., Silva el V.G., Hess K.R., Gershenson D.M., et al. Expression of metastasis-related genes in human epithelial ovarian tumors. Int J Oncol 20 (2002) 5-13
19. Kuittinen O., Savolainen E.R., Koistinen P., and Turpeenniemi-Hujanen T. Gelatinase A and B (MMP-2, MMP-9) in leukaemia MMP-2 may indicate a good prognosis in AML. Anticancer Res 19 (1999) 4395-4400
20. El-Obeid A., Sunnuqrut N., Hussain A., Al-Hussein K., Gutierrez M.I., and Bhatia K. Immature B cell malignancies synthesize VEGF, VEGFR-1 (Flt-1) and VEGFR-2 (KDR). Leuk Res 28 (2004) 133-137
21. Lenormand B., Bene M.C., Lesesve J.F., Bastard C., Tilly H., Lefranc M.P., et al. PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des Leucemies. Leuk Lymphoma 28 (1998) 329-342
22. Pegahi R., Poyer F., Legrand E., Cazin L., Vannier J.P., and Lamacz M. Spontaneous and cytokine-evoked production of matrix metalloproteinases by bone marrow and peripheral blood pre-B cells in childhood acute lymphoblastic leukaemia. Eur Cytokine Network 16 (2005) 223-232
23. Whittle C., Gillespie K., Harrison R., Mathieson P.W., and Harper S.J. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant. Clin Sci 97 (1999) 303-312
24. Shintani S., Li C., Ishikawa T., Mihara M., Nakashiro K., and Hamakawa H. Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma. Oral Oncol 40 (2004) 13-20
25. Dias S., Hattori K., Zhu Z., Heissig B., Choy M., Lane W., et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest 106 (2000) 511-521
26. Gill M., Dias S., Hattori K., Rivera M.L., Hicklin D., Witte L., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 88 (2001) 167-174
27. Liu X.E., Sun X.D., and Wu J.M. Expression and significance of VEGF-C and FLT-4 in gastric cancer. World J Gastroenterol 10 (2004) 352-355
28. Vasse M., Denoyelle C., Legrand E., Vannier J.P., and Soria C. Weak regulation of protein Z biosynthesis by inflammatory cytokines. Thromb Haemost 87 (2002) 350-351
29. Hammond D., Sather H., Nesbit M., Miller D., Coccia P., Bleyer A., et al. Analysis of prognostic factors in acute lymphoblastic leukemia. Med Pediatr Oncol 14 (1986) 124-134
30. Settin A., Al Haggar M., Al Dosoky T., Al Baz R., Abdelrazik N., Fouda M., et al. Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia: cases from Mansoura. Egypt Hematol 11 (2006) 341-349
31. Smith M., Bleyer A., Crist W., Murphy S., and Sallan S.E. Uniform criteria for childhood acute lymphoblastic leukemia risk classification. J Clin Oncol 14 (1996) 680-681
32. Donadieu J., Auclerc M.F., Baruchel A., Perel Y., Bordigoni P., Landman-Parker J., et al. Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE). Br J Cancer 83 (2000) 1617-1622
33. Bagley R.G., Walter-Yohrling J., Cao X., Weber W., Simons B., Cook B.P., et al. Endothelial precursor cells as a model of tumor endothelium: characterization and comparison with mature endothelial cells. Cancer Res 63 (2003) 5866-5873
34. Wang J.F., Zhang X., and Groopman J.E. Activation of vascular endothelial growth factor receptor-3 and its downstream signaling promote cell survival under oxidative stress. J Biol Chem 279 (2004) 27088-27097
35. Billottet C., Janji B., Thiery J.P., and Jouanneau J. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2. Oncogene 21 (2002) 8128-8139
36. Ueda M., Terai Y., Kumagai K., Ueki K., Yamaguchi H., Akise D., et al. Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells. Gynecol Oncol 82 (2001) 162-166
37. Santos S.C., and Dias S. Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways. Blood 103 (2004) 3883-3889
38. Fragoso R., Pereira T., Wu Y., Zhu Z., Cabecadas J., and Dias S. VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease. Blood 107 (2006) 1608-1616
39. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 55 (2000) 15-35 discussion at pp. 35-36
40. Vieira J.M., Santos S.C., Espadinha C., Correia I., Vag T., Casalou C., et al. Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop. Eur J Endocrinol 153 (2005) 701-709
41. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 (1997) 4-25
42. Kahn C.R., Baird K.L., Flier J.S., Grunfeld C., Harmon J.T., Harrison L.C., et al. Insulin receptors, receptor antibodies, and the mechanism of insulin action. Recent Prog Horm Res 37 (1981) 477-538
43. Couraud P.O., Delavier-Klutchko C., Durieu-Trautmann O., and Strosberg A.D. Antibodies raised against beta-adrenergic receptors stimulate adenylate cyclase. Biochem Biophys Res Commun 99 (1981) 1295-1302
44. Leiber D., Harbon S., Guillet J.G., Andre C., and Strosberg A.D. Monoclonal antibodies to purified muscarinic receptor display agonist-like activity. Proc Natl Acad Sci USA 81 (1984) 4331-4334
45. Dias S., Choy M., Alitalo K., and Rafii S. Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy. Blood 99 (2002) 2179-2184
46. Schneider P., Vasse M., Sbaa-Ketata E., Lenormand B., Hong L., Soria C., et al. The growth of highly proliferative acute lymphoblastic leukemia may be independent of stroma and/or angiogenesis. Leukemia 15 (2001) 1143-1145